59 North Communications at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

59 North Communications takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on biotech ecosystems, asking what makes a global biotech hub work and how AI and digital collaboration are changing drug discovery. It shares the stage with investors such as Novo Holdings and OKG Capital.

OrganizationBIO-Europe 2026 Attendance
59 North Communications
Stockholm, Sweden
Consulting, legal & services
Communications agency providing branding, PR and digital marketing for life science, biotech and pharmaceutical companies.
Panel
Mon Nov 9
16:15–17:00
Building the Next Global Biotech Hubs: What Makes an Innovation Ecosystem Work?
What makes a region a strong biotech hub, from talent, labs and funding to links with global drug companies.
with Gateway Factory, Grove Biopharma, Novo Holdings +2 more
Panel
Wed Nov 11
13:00–13:45
AI-Powered Ecosystems: Transforming Drug Discovery Through Digital Collaboration
How drug, biotech and tech companies can build AI partnerships, and why AI finds easier wins in early discovery than in later clinical stages.
with OKG Capital, endogene.bio, Insilico Medicine +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from 59 North Communications

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction